Literature DB >> 21166882

Germline polymorphisms of glutathione-S-transferase GSTM1, GSTT1 and p53 codon 72 in cervical carcinogenesis.

Masatsugu Ueda1, Eisaku Toji, Osamu Nunobiki, Naomi Sato, Shinji Izuma, Kiyo Torii, Yoshiaki Okamoto, Sadamu Noda.   

Abstract

The clinical significance of glutathione-S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in cervical carcinogenesis was investigated. Germline polymorphisms of GSTM1, GSTT1 and p53 codon 72 together with human papillomavirus (HPV) types were examined in a total of 457 blood and cervical smear samples from normal healthy women and the patients with premalignant and malignant cervical lesions. The 167 patients with low-grade squamous intraepithelial lesion (LSIL), 49 with high-grade SIL (HSIL) and 83 with squamous cell carcinoma (SCC) had significantly higher frequency of high-risk HPV than 158 controls. The 49 patients with HSIL and 83 with SCC had statistically higher frequency of null GSTT1 genotype than 158 controls. There was an increased odds ratio for null GSTT1 genotype in HSIL and SCC cases compared with controls among 191 patients with high-risk HPV. The 67 cases with HPV types 16 and/or 18 had higher frequency of the GSTT1 null genotype than 186 with other types of HPV. There was no statistical difference in the polymorphic frequency of GSTM1 and p53 codon 72 genotypes between SILs and controls with or without high-risk HPV. These results suggest that GSTT1 null genotype may increase the risk of cervical cancer particularly in the cases with high-risk HPV types in a Japanese population. 2010 The Authors. Human Cell 2010 Japan Human Cell Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21166882     DOI: 10.1111/j.1749-0774.2010.00089.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  32 in total

1.  p53 polymorphism and risk of cervical cancer.

Authors:  S Lanham; I Campbell; P Watt; R Gornall
Journal:  Lancet       Date:  1998-11-14       Impact factor: 79.321

2.  Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus.

Authors:  L A Brooks; J A Tidy; B Gusterson; L Hiller; J O'Nions; M Gasco; M C Marin; P J Farrell; W G Kaelin; T Crook
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

3.  Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

Authors:  A Storey; M Thomas; A Kalita; C Harwood; D Gardiol; F Mantovani; J Breuer; I M Leigh; G Matlashewski; L Banks
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

4.  Association of multiple human papillomavirus types with vulvar neoplasias.

Authors:  H Nagano; H Yoshikawa; T Kawana; H Yokota; Y Taketani; H Igarashi; H Yoshikura; A Iwamoto
Journal:  J Obstet Gynaecol Res       Date:  1996-02       Impact factor: 1.730

5.  Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes.

Authors:  S Baez; J Segura-Aguilar; M Widersten; A S Johansson; B Mannervik
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

6.  Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks.

Authors:  C L Chen; Q Liu; M V Relling
Journal:  Pharmacogenetics       Date:  1996-04

7.  Glutathione S-transferase M1 genotypes and the risk of squamous carcinoma of the cervix: a population-based case-control study.

Authors:  C Chen; M M Madeleine; N S Weiss; J R Daling
Journal:  Am J Epidemiol       Date:  1999-09-15       Impact factor: 4.897

8.  p53 codon 72 polymorphism and risk of cervical cancer in UK.

Authors:  A N Rosenthal; A Ryan; R M Al-Jehani; A Storey; C A Harwood; I J Jacobs
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

Review 9.  p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review.

Authors:  Anita Koushik; Robert W Platt; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254

10.  Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci.

Authors:  J Elexpuru-Camiruaga; N Buxton; V Kandula; P S Dias; D Campbell; J McIntosh; J Broome; P Jones; A Inskip; J Alldersea
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

View more
  2 in total

1.  The association of GSTM1 and GSTT1 polymorphisms with squamous cell carcinoma of cervix in Pakistan.

Authors:  Sarah Hasan; Abdul Hameed; Saima Saleem; S M Shahid; Ghulam Haider; Abid Azhar
Journal:  Tumour Biol       Date:  2015-02-09

2.  Relationship between GSTM1 and GSTT1 polymorphisms and HPV infection: a systematic review.

Authors:  Ana Paula Reolon Bortolli; Valquíria Kulig Vieira; Emi Elaine Stefanski; Angela Khetly Lazarotto; Léia Carolina Lucio
Journal:  Mol Biol Rep       Date:  2021-08-13       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.